Arbitel Trio 25/40/10mg Tablet ER 10s is a combination medicine containing Cilnidipine, Metoprolol Succinate, and Telmisartan. It is primarily used to manage high blood pressure (hypertension) and related cardiovascular conditions. Cilnidipine relaxes blood vessels, Metoprolol slows the heart rate, and Telmisartan blocks the effects of angiotensin II, thereby improving blood flow. This triple combination helps in effective blood pressure control and reduces the risk of heart attack and stroke when taken as prescribed by a doctor.
Written by: Syed Jommy Abbas, B. Pharma
Reviewed by: Dr. Devika Rani, MBBS
Last updated on: 21-05-2026
Delivery by
...
WHO GMP Certified
Long Expiry (>8 Months)
15 Days Easy Returns
Genuine Medicine
Pay On Delivery
Secure Payment
LegitScript Certified Online Pharmacy
Arbitel Trio 25/40/10mg Tablet ER 10s is a combination medicine containing Cilnidipine, Metoprolol Succinate, and Telmisartan. It is primarily used to manage high blood pressure (hypertension) and related cardiovascular conditions. Cilnidipine relaxes blood vessels, Metoprolol slows the heart rate, and Telmisartan blocks the effects of angiotensin II, thereby improving blood flow. This triple combination helps in effective blood pressure control and reduces the risk of heart attack and stroke when taken as prescribed by a doctor.
Arbitel Trio 25/40/10mg Tablet ER 10s is a fixed-dose triple combination medication used in the treatment of hypertension, especially in patients who require multiple drugs for adequate blood pressure control. It contains Cilnidipine, Metoprolol Succinate, and Telmisartan, each acting through different mechanisms to provide synergistic effects.
Cilnidipine is a calcium channel blocker (CCB) that inhibits L-type and N-type calcium channels, leading to relaxation of vascular smooth muscles and reduction in peripheral resistance. This helps in lowering blood pressure without causing excessive reflex tachycardia.
Metoprolol Succinate is a selective beta-1 adrenergic blocker that reduces heart rate, myocardial contractility, and cardiac output. It reduces the workload on the heart and is particularly useful in patients with hypertension and heart disease.
Telmisartan is an angiotensin II receptor blocker (ARB) that prevents vasoconstriction and aldosterone secretion by blocking angiotensin II receptors. This results in blood vessel dilation and reduced blood pressure.
This triple combination is often prescribed in patients with uncontrolled hypertension despite dual therapy. It not only helps in effective blood pressure management but also provides cardiovascular protection by reducing the risk of stroke, myocardial infarction, and kidney damage. Regular monitoring and adherence to treatment are essential for optimal outcomes.
Arbitel Trio 25/40/10mg Tablet ER 10s works through a combination of three active components. Cilnidipine blocks calcium channels in blood vessels, causing vasodilation and reduced peripheral resistance.
Metoprolol Succinate selectively blocks beta-1 receptors in the heart, reducing heart rate and cardiac output, thereby lowering blood pressure.
Telmisartan blocks angiotensin II receptors, preventing vasoconstriction and reducing fluid retention. This leads to relaxation of blood vessels and improved blood flow.
Together, these mechanisms provide effective and sustained blood pressure control and cardiovascular protection.
Arbitel Trio 25/40/10mg Tablet ER 10s can be taken with or without food. However, certain dietary factors may influence its effectiveness. High potassium-containing foods may increase potassium levels when taken with Telmisartan. Alcohol may enhance hypotensive effects and increase dizziness.
Key interactions include:
Arbitel Trio 25/40/10mg Tablet ER 10s may interact with several medications, affecting its safety and effectiveness.
Important drug interactions include:
Drug–Disease Interactions of Arbitel Trio 25/40/10mg Tablet ER 10s
This medicine should be used cautiously in patients with certain medical conditions. Its components may affect heart, kidney, and liver functions.
Use with caution in the following conditions:
Take Arbitel Trio 25/40/10mg Tablet ER 10s exactly as prescribed by your doctor. The dosage depends on your blood pressure and overall health. Do not alter the dose without consulting your doctor.
Overdose of Arbitel Trio 25/40/10mg Tablet ER 10s may lead to severe hypotension, dizziness, fainting, slow heart rate, or kidney dysfunction. Immediate medical attention is required in such cases.
If you miss a dose, take it as soon as you remember. If it is close to your next dose, skip the missed dose and continue your regular schedule. Do not take a double dose to make up for a missed dose.
Therapeutic Class
Antihypertensive
Action Class
Calcium channel blocker + Beta-1 blocker + Angiotensin receptor blocker
Chemical Class
CCB + Beta-blocker + ARB
Habit Forming
No
PlatinumRx is committed to providing reliable and accurate information to support informed customer decisions. However, all information made available on the Platform, including product descriptions, comparisons, and other content, is provided solely for general informational purposes. Such information is not intended to diagnose, prevent, treat, or cure any medical condition, nor should it be relied upon as a substitute for professional medical advice, diagnosis, or treatment.

More Medicines By Manufacturer
More Medicines With Salt
Top Selling Medicines
Top Selling Devices